LPL Financial’s SELLAS Life Sciences SLS Stock Holding History

LPL Financial’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,000	Closed	-$41.5K	–	6142
2025 Q4	$41.5K	Buy	+11,000	New	+$21.4K	﹤0.01%	5723

Other funds holding SLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LPL Financial's SLS Position: Q1 2026 in Review

LPL Financial increased its SELLAS Life Sciences (SLS) stake by 42% in Q1 2026, buying an estimated $183K and bringing the position to 137,208 shares worth $580K. The position accounts for ﹤0.01% of the portfolio, ranked #4631.

LPL Financial first reported a position in SLS in Q2 2024 and has held it in 8 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

LPL Financial held 137,208 shares of SELLAS Life Sciences worth $580K as of Q1 2026.
LPL Financial bought 40,903 SELLAS Life Sciences shares in Q1 2026, an estimated $183K.
SELLAS Life Sciences made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #4631 holding.
LPL Financial first reported a position in SELLAS Life Sciences in Q2 2024 and has held it in 8 quarters since.
160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.